Home
About
Overview
Sharing Data
ORCID
Help
History (10)
A Bayesian approach for edge extraction in medical ultrasound image
Secretion of a nerve growth factor by primary chick fibroblast cultures.
Shining a Light on the Dark Side.
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase.
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers. J Natl Cancer Inst. 2013 Jan 02; 105(1):11-24.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Biomarkers, Tumor
Cell Hypoxia
Clinical Trials as Topic
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Cytostatic Agents
Cytotoxins
Disease Models, Animal
DNA Damage
DNA Repair
Drug Administration Schedule
Drug Design
ErbB Receptors
Gene Expression Regulation, Neoplastic
Humans
Immunologic Factors
Molecular Targeted Therapy
National Cancer Institute (U.S.)
Neoplasms
Radiation-Sensitizing Agents
Radiotherapy
Research Design
Signal Transduction
Time Factors
United States
authors with profiles
James J. Dignam